Clinical Trial Update: Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks [NA]

View source ↗

Summary

A Norwegian clinical trial is evaluating screening for preeclampsia with aspirin discontinued at 24-28 weeks of gestation; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: St. Olavs Hospital | Conditions: Pre-Eclampsia | NA | Status: RECRUITING